ADAR RNA modifications, the epitranscriptome and innate immunity
Modified bases act as marks on cellular RNAs so that they can be distinguished from foreign
RNAs, reducing innate immune responses to endogenous RNA. In humans, mutations …
RNAs, reducing innate immune responses to endogenous RNA. In humans, mutations …
Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: an update
M Kono, M Akiyama - Journal of Dermatological Science, 2019 - Elsevier
Dyschromatosis symmetrica hereditaria (DSH) and reticulate acropigmentation of Kitamura
(RAK) are rare, inherited pigmentary diseases. DSH shows a mixture of pigmented and …
(RAK) are rare, inherited pigmentary diseases. DSH shows a mixture of pigmented and …
The prototypical interferonopathy: Aicardi‐Goutières syndrome from bedside to bench
Aicardi‐Goutières syndrome (AGS) is a progressive genetic encephalopathy caused by
pathogenic mutations in genes controlling cellular anti‐viral responses and nucleic acid …
pathogenic mutations in genes controlling cellular anti‐viral responses and nucleic acid …
EpisomiR, a new family of miRNAs, and its possible roles in human diseases
Y Arao, M Nakayama, Y Tsuji, Y Hamano, C Otsuka… - Biomedicines, 2022 - mdpi.com
MicroRNAs (miRNAs) are synthesized through a canonical pathway and play a role in
human diseases, such as cancers and cardiovascular, neurodegenerative, psychiatric, and …
human diseases, such as cancers and cardiovascular, neurodegenerative, psychiatric, and …
Movement disorders in ADAR1 disease: Insights from a comprehensive cohort
G Di Lazzaro, F Graziola, A Sancesario… - Parkinsonism & Related …, 2020 - Elsevier
ADAR1 variants are associated to rare and heterogenous neurological conditions, including
Aicardi-Goutières syndrome type 6, bilateral striatal necrosis, and dyschromatosis …
Aicardi-Goutières syndrome type 6, bilateral striatal necrosis, and dyschromatosis …
Pathogenesis of a variant in the 5′ untranslated region of ADAR1 in dyschromatosis symmetrica hereditaria
M Suganuma, M Kono, M Yamanaka… - Pigment Cell & …, 2020 - Wiley Online Library
Dyschromatosis symmetrica hereditaria (DSH) is a pigmentary genodermatosis caused by
mutations in ADAR1. In this study, we performed mutation analysis on a family that included …
mutations in ADAR1. In this study, we performed mutation analysis on a family that included …
Dyschromatosis symmetrica hereditaria may be successfully controlled by topical sunscreen
M Kono, T Okamoto, T Takeichi, Y Muro… - European Journal of …, 2018 - jle.com
Dyschromatosis symmetrica hereditaria (DSH) is caused by a heterozygous ADAR1
mutation [1] and is characterized by a mixture of hyper-and hypo-pigmented small macules …
mutation [1] and is characterized by a mixture of hyper-and hypo-pigmented small macules …
RNA editing in interferonopathies
L Frassinelli, S Galardi, SA Ciafrè… - RNA Editing: Methods and …, 2021 - Springer
The type I interferonopathies comprise a heterogenous group of monogenic diseases
associated with a constitutive activation of type I interferon signaling. The elucidation of the …
associated with a constitutive activation of type I interferon signaling. The elucidation of the …
Dyschromatosis symmetrica hereditaria with chilblains due to a novel two‐amino‐acid deletion in the double‐stranded RNA‐binding domain of ADAR1.
M Kono, M Suganuma, T Takeichi… - Journal of the …, 2018 - search.ebscohost.com
The article presents a case study on the detection of ADAR1 mutation in a seven-year-old
girl with skin disease dyschromatosis symmetrica hereditaria and chilblains due to the …
girl with skin disease dyschromatosis symmetrica hereditaria and chilblains due to the …
Identification of Two Novel Frameshift Mutations of the ADAR1 Gene in Two Chinese Families With Dyschromatosis Symmetrica Hereditaria
X Ning, S Xiao, Y Zhang - Indian Journal of Dermatology, 2022 - journals.lww.com
Background: Dyschromatosis symmetrica hereditaria (DSH) is a rare autosomal dominant
skin disease. The mutation of the ADAR1 gene is the pathogenesis of this disorder. Aims …
skin disease. The mutation of the ADAR1 gene is the pathogenesis of this disorder. Aims …